Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04858022 · ClinicalTrials.gov registry record · Phase 2
Visual Acoustic Biofeedback for RSE Via Telepractice
A Phase 2 study of Speech Sound Disorder, sponsored by Montclair State University.
- Completed
- Registry status
- Phase 2
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT04858022: Completed Phase 2 study of Speech Sound Disorder, sponsored by Montclair State University.
NCT04858022 is a Phase 2 study of Speech Sound Disorder that has completed, run by Montclair State University. The registered enrollment target is 40 participants, below the 87-participant average among 15 other Speech Sound Disorder trials with a reported enrollment target (54% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04858022, a Phase 2 study of Speech Sound Disorder, has completed, sponsored by Montclair State University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
This research will meet a public health need by evaluating the efficacy of speech intervention supplemented with real-time visual-acoustic biofeedback when delivered using remote technologies.
Primary Outcome
To evaluate the generalization of treatment effects to untreated words, participants will complete standardized word probes comprising 50 target words. The primary outcome measure is the proportion of words rated as "correct" across all tokens, reflecting perceptual accuracy of the participant's responses.
Conditions Studied
Interventions
- OTHER No Treatment
- BEHAVIORAL Visual-Acoustic Biofeedback Treatment
Study Locations (1)
New Jersey
- Montclair State University - Upper Montclair
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2022-01-15 |
| Est. Completion | 2024-04-15 |
| Phase | Phase 2 |
What the finished NCT04858022 record still lists
NCT04858022 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 87-participant average among 15 other Speech Sound Disorder trials with a reported enrollment target (54% lower).
The record links to 1 condition, with Speech Sound Disorder appearing as the primary indexed condition, and to 2 interventions - of which No Treatment is the first listed.
NCT04858022 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT04858022 about?
NCT04858022 is a clinical study titled "Visual Acoustic Biofeedback for RSE Via Telepractice". This research will meet a public health need by evaluating the efficacy of speech intervention supplemented with real-time visual-acoustic biofeedback when delivered using remote technologies.
What is the current status of trial NCT04858022?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 40 participants. The study started on 2022-01-15. Estimated completion is 2024-04-15.
What conditions does trial NCT04858022 study?
This clinical trial studies the following conditions: Speech Sound Disorder.
What interventions are being tested in trial NCT04858022?
The interventions under investigation include: No Treatment (OTHER), Visual-Acoustic Biofeedback Treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT04858022?
This trial is sponsored by Montclair State University, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04858022 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Speech Sound Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04858022's enrollment target sits among peer trials
40 11th of 15 higher than 5 of 15 other Speech Sound Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Speech Sound Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Visual-acoustic Intervention With Service Delivery In-person and Via Telepractice Trial
RECRUITING · Phase 2
-
Generalization With AI Navigation Using StaRt
RECRUITING · Phase 2
-
Orthognathic Speech Pathology: Phonetic Contrasts of Patients With Dental Discrepancies Pre- and Post-Treatment Analyses
RECRUITING
-
Simplified Ultrasound Feedback for Speech Remediation
RECRUITING · NA
-
A Developmental Framework For Linking Phonological And Morpho-syntactic Sequential Pattern Rules In DLD: Production
RECRUITING · NA
-
Evaluating the Effectiveness of Hybrid and Traditional Speech Therapy for /ɹ/ and /s/ Sound Production
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI